ibritumomab tiuxetan   Click here for help

GtoPdb Ligand ID: 6777

Synonyms: IDEC-2B8 | IDEC-Y2B8-yttrium ibritumomab tiuxetan | NSC-715848 | Zevalin®
Approved drug Immunopharmacology Ligand
ibritumomab tiuxetan is an approved drug (FDA (2002), EMA (2004))
Compound class: Antibody
Comment: A monoclonal antibody used as a radioimmunotherapy treatment.
Classification Click here for help
Compound class Antibody
Approved drug? Yes (FDA (2002), EMA (2004))
International Nonproprietary Names Click here for help
INN number INN
7873 ibritumomab tiuxetan
Synonyms Click here for help
IDEC-2B8 | IDEC-Y2B8-yttrium ibritumomab tiuxetan | NSC-715848 | Zevalin®
Database Links Click here for help
Specialist databases
IMGT/mAb-DB 122
Other databases
GtoPdb PubChem SID 178103383
PubChem SID 178103383
Search PubMed clinical trials ibritumomab tiuxetan
Search PubMed titles ibritumomab tiuxetan
Search PubMed titles/abstracts ibritumomab tiuxetan
Wikipedia Ibritumomab_tiuxetan